![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Guenther, Michael; Surendran, Sai Agash; Haas, Michael; Heinemann, Volker; Bergwelt-Baildon, Michael von 
ORCID: https://orcid.org/0000-0002-1952-052X; Engel, Jutta; Werner, Jens; Boeck, Stefan ORCID: https://orcid.org/0000-0002-1922-2127 und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2023):
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
In: British Journal of Cancer, Bd. 129: S. 175-182
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-1952-052X; Engel, Jutta; Werner, Jens; Boeck, Stefan ORCID: https://orcid.org/0000-0002-1922-2127 und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2023):
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
In: British Journal of Cancer, Bd. 129: S. 175-182
[PDF, 1MB]
Guenther, Michael; Boeck, Stefan; Heinemann, Volker; Werner, Jens; Engel, Jutta und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2022):
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer.
In: International Journal of Cancer, Bd. 151, Nr. 6: S. 914-919
[PDF, 443kB]
ORCID: https://orcid.org/0000-0002-0754-9034
(2022):
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer.
In: International Journal of Cancer, Bd. 151, Nr. 6: S. 914-919
[PDF, 443kB]
Guenther, Michael; Gil, Lina; Surendran, Sai Agash; Palm, Melanie Alexandra; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Mayerle, Julia; Engel, Jutta; Werner, Jens; Boeck, Stefan und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2022):
Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer.
In: JNCI Cancer Spectrum, Bd. 6, Nr. 3, pkac039
[PDF, 555kB]
ORCID: https://orcid.org/0000-0002-1349-3321; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Mayerle, Julia; Engel, Jutta; Werner, Jens; Boeck, Stefan und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2022):
Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer.
In: JNCI Cancer Spectrum, Bd. 6, Nr. 3, pkac039
[PDF, 555kB]
Dorman, Klara; Gerckens, Miriam; Kruger, Stephan; Krueger, Kimberly; Mayer, Zsuzsanna; Rupp, Alexander; Zhang, Danmei; Weiss, Lena; Westphalen, C. Benedikt; Haas, Michael; Guenther, Michael; Ormanns, Steffen; Klawonn, Frank; Werner, Jens; Bergwelt-Baildon, Michael von; Heinemann, Volker; Böck, Stefan und Holdenrieder, Stefan
(2022):
Serum biomarker panel diagnostics in pancreatic ductal adenocarcinoma: the clinical utility of soluble interleukins, IFN-gamma, TNF-alpha and PD-1/PD-L1 in comparison to established serum tumor markers.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 6: S. 2463-2474
[PDF, 1MB]
Guenther, Michael; Haas, Michael; Heinemann, Volker; Kruger, Stephan; Westphalen, Christoph Benedikt; Bergwelt-Baildon, Michael von; Mayerle, Julia; Werner, Jens; Kirchner, Thomas; Boeck, Stefan und Ormanns, Steffen
(2020):
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study.
In: British Journal of Cancer, Bd. 123, Nr. 9: S. 1370-1376
Marfels, Christian; Hoehn, Miriam; Wagner, Ernst und Guenther, Michael
(2013):
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities.
In: BMC Cancer
13:176
[PDF, 3MB]